AmplifyBio’s 2024 Tox Talk Presentation
AmplifyBio’s 2024 Tox Talk Presentation Download the 2024 Tox Talk Presentation Advanced Strategies and Methods for Safety Testing Next-Generation Therapeutics As more cell and gene therapies advance in development, toxicology assessment of these therapies is evolving to encompass new testing strategies and embrace new endpoints to assess potential physiological changes. Contact Us As an expert contract […]
Innovation Thrives where R&D and CMC Unite – The Product is the Product
Integrating Research & Development (R&D) with Chemistry, Manufacturing, and Controls (CMC) is not just a best practice—it’s essential when scaling up advanced therapies. The success of therapies hinges on seamless collaboration between these critical functions from the outset, ensuring they are groundbreaking, manufacturable, scalable, and regulatory-compliant. However, despite progress in embracing advanced analytics, data science, […]
AmplifyBio Partners with Silo Pharma to Initiate Pharmacokinetic and Tolerability Study
AmplifyBio is proud to be the preclinical CRO partner of choice for Silo Pharma Inc. as they advance their ground-breaking drug candidate for chronic pain through a critical safety milestone. “AmplifyBio is honored to support Silo Pharma in this critical safety milestone for SP-26. We understand and take seriously the trust put in us to […]
AmplifyBio Plasmid Flyer
AmplifyBio Plasmid Design and Manufacturing Services Flyer Download Plasmid Design and Manufacturing Services Flyer AmplifyBio’s Plasmid Manufacturing Platform delivers GMP-quality plasmids at any scale, with no minimum yield requirements. Learn more about our plasmid design and manufacturing services in this flyer. Contact Us As an expert contract research organization (CRO), AmplifyBio leverages decades of experience […]
AmplifyBio Partners with Industry Leader in Lipid Nanoparticles (LNPs) to Expand Drug Delivery Capabilities
WEST JEFFERSON, Ohio, July 30, 2024 (Newswire.com) – AmplifyBio, an emerging leader among mRNA discovery, development, and manufacturing service providers, announced today that it has formalized a partnership with Stephen Burgess, Ph.D. (AvaBurg LLC), to provide expertise in LNP formulations to ensure efficient encapsulation, protection, and delivery of mRNA to cells. Dr. Burgess formerly served as Chief […]
ISCT2024 Poster: Adapting T cells for the Tumor Microenvironment (TME) During Manufacturing for Improved Anti-Tumor Potency
ISCT2024 Poster – Adapting T cells for the Tumor Microenvironment (TME) During Manufacturing for Improved Anti-Tumor Potency Adapting T cells for the Tumor Microenvironment (TME) During Manufacturing for Improved Anti-Tumor Potency Enhancing T-cell fitness in solid tumors is vital for effective therapies. In this poster, AmplifyBio uses the Avatar incubator to create low-oxygen, high-pressure […]
ISCT2024 Poster: AmplifyBio TCR Specificity Platform: Better Off-target Assessment for Safer TCR-based Therapies
ISCT2024 Poster – AmplifyBio TCR Specificity Platform: Better Off-target Assessment for Safer TCR-based Therapies AmplifyBio TCR Specificity Platform: Better Off-target Assessment for Safer TCR-based Therapies AmplifyBio’s TCR Specificity Platform enhances TCR-T cell therapy development by integrating peptide positional flexibility assessment, comprehensive human proteome searches, tissue gene expression, in silico machine learning predictions, and cell-based assays. […]
Mitigating Risk, Maximizing Quality: AmplifyBio’s Data Integrity Journey
By: Amy Adams, Systems Analyst At AmplifyBio, we understand the critical role data integrity plays in achieving successful outcomes. While spreadsheets are a cornerstone of many businesses, they can introduce errors due to their inherent ease of use and accessibility. This is especially concerning in GxP-regulated environments, where compliance with 21 CFR Part 11 is […]
AmplifyBio Expands Capacity for Advanced Therapy Pathology Services
An integral part of AmplifyBio’s vision is to continuously assess the needs of our clients and invest in valuable, differentiating, and translational capabilities to serve the needs of advanced therapy development. An example of that commitment comes from the growth of cell and gene therapy and other biologic modalities, causing a notable shift in the […]
AmplifyBio and Xcell Biosciences Announce Partnership to Manufacture Solid Tumor-Targeting TCR-T Cell Therapy
Companies will jointly work through process development, preclinical analysis, and first-in-human trials using Xcellbio’s AVATAR FoundryTM platform SAN FRANCISCO and SOUTH SAN FRANCISCO, CA — May 20, 2024 – Xcell Biosciences Inc. (Xcellbio), an innovative technology company focused on cell and gene therapy manufacturing applications, and AmplifyBio, a rapidly growing contract development and manufacturing organization, […]
